|
Bionano Genomics, Inc. (BNGO) Valoración de DCF
US | Healthcare | Medical - Diagnostics & Research | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Bionano Genomics, Inc. (BNGO) Bundle
¡Simplifique la valoración de Bionano Genomics, Inc. (BNGO) con esta calculadora DCF personalizable! Con el Real Bionano Genomics, Inc. (BNGO) finanzas y entradas de pronóstico ajustables, puede probar escenarios y descubrir el valor razonable de Bionano Genomics, Inc. (BNGO) en minutos.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.1 | 8.5 | 18.0 | 27.8 | 36.1 | 51.3 | 72.9 | 103.7 | 147.3 | 209.4 |
| Revenue Growth, % | 0 | -16.06 | 111.47 | 54.62 | 29.9 | 42.12 | 42.12 | 42.12 | 42.12 | 42.12 |
| EBITDA | -26.4 | -37.1 | -73.9 | -120.3 | -213.6 | -51.3 | -72.9 | -103.7 | -147.3 | -209.4 |
| EBITDA, % | -260.43 | -436.12 | -410.74 | -432.76 | -591.44 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | 1.1 | 1.5 | 4.0 | 10.1 | 13.7 | 12.8 | 18.2 | 25.9 | 36.8 | 52.3 |
| Depreciation, % | 11.13 | 17.34 | 22.08 | 36.32 | 37.96 | 24.97 | 24.97 | 24.97 | 24.97 | 24.97 |
| EBIT | -27.5 | -38.6 | -77.8 | -130.4 | -227.3 | -51.3 | -72.9 | -103.7 | -147.3 | -209.4 |
| EBIT, % | -271.56 | -453.47 | -432.82 | -469.08 | -629.39 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 17.3 | 38.4 | 250.6 | 113.2 | 101.9 | 51.3 | 72.9 | 103.7 | 147.3 | 209.4 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 6.3 | 2.8 | 4.9 | 7.0 | 9.7 | 17.9 | 25.5 | 36.2 | 51.4 | 73.1 |
| Account Receivables, % | 62.53 | 32.64 | 27.44 | 25.26 | 26.75 | 34.92 | 34.92 | 34.92 | 34.92 | 34.92 |
| Inventories | 3.4 | 3.3 | 12.4 | 29.8 | 22.9 | 31.3 | 44.5 | 63.3 | 89.9 | 127.8 |
| Inventories, % | 34 | 38.99 | 68.89 | 107.05 | 63.38 | 61.05 | 61.05 | 61.05 | 61.05 | 61.05 |
| Accounts Payable | 2.7 | 2.9 | 9.7 | 12.5 | 10.4 | 19.4 | 27.6 | 39.2 | 55.6 | 79.1 |
| Accounts Payable, % | 26.65 | 34.45 | 53.92 | 45.08 | 28.75 | 37.77 | 37.77 | 37.77 | 37.77 | 37.77 |
| Capital Expenditure | -.1 | .0 | -1.5 | -3.3 | -1.7 | -2.6 | -3.7 | -5.2 | -7.4 | -10.6 |
| Capital Expenditure, % | -0.60275 | 0 | -8.12 | -11.88 | -4.68 | -5.06 | -5.06 | -5.06 | -5.06 | -5.06 |
| Tax Rate, % | -0.02667458 | -0.02667458 | -0.02667458 | -0.02667458 | -0.02667458 | -0.02667458 | -0.02667458 | -0.02667458 | -0.02667458 | -0.02667458 |
| EBITAT | -27.5 | -38.6 | -72.1 | -132.3 | -227.4 | -50.6 | -71.9 | -102.1 | -145.2 | -206.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -33.5 | -33.2 | -74.1 | -142.1 | -213.3 | -48.1 | -69.9 | -99.4 | -141.2 | -200.7 |
| WACC, % | 7.21 | 7.21 | 6.78 | 7.21 | 7.21 | 7.12 | 7.12 | 7.12 | 7.12 | 7.12 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -436.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -205 | |||||||||
| Terminal Value | -3,997 | |||||||||
| Present Terminal Value | -2,833 | |||||||||
| Enterprise Value | -3,269 | |||||||||
| Net Debt | 61 | |||||||||
| Equity Value | -3,331 | |||||||||
| Diluted Shares Outstanding, MM | 34 | |||||||||
| Equity Value Per Share | -97.54 |
What You Will Get
- Real BNGO Financials: Includes historical and forecasted data for accurate valuation.
- Adjustable Inputs: Modify WACC, tax rates, revenue growth, and capital expenditures.
- Automatic Calculations: Intrinsic value and NPV are calculated dynamically.
- Scenario Analysis: Test multiple scenarios to evaluate Bionano Genomics’ future performance.
- Clear and Intuitive Design: Built for professionals yet accessible for beginners.
Key Features
- Comprehensive Genomic Data: Access reliable pre-loaded historical data and future projections for Bionano Genomics (BNGO).
- Tailored Analysis Parameters: Modify highlighted cells for key metrics like growth rates, sequencing costs, and market penetration.
- Real-Time Updates: Automatic recalculations for financial models, including DCF, Net Present Value (NPV), and revenue forecasts.
- Interactive Visualization Tools: User-friendly charts and summaries to effectively present your genomic analysis outcomes.
- Designed for All Levels: An accessible layout suitable for researchers, analysts, and industry professionals.
How It Works
- Step 1: Download the prebuilt Excel template with Bionano Genomics’ data included.
- Step 2: Explore the pre-filled sheets and familiarize yourself with the key metrics.
- Step 3: Update forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly view recalculated results, including Bionano Genomics’ intrinsic value.
- Step 5: Make informed investment decisions or generate reports using the outputs.
Why Choose This Calculator for Bionano Genomics, Inc. (BNGO)?
- Accurate Data: Real Bionano Genomics financials ensure reliable valuation results.
- Customizable: Adjust key parameters like growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Pre-built calculations streamline the process, eliminating the need to start from scratch.
- Professional-Grade Tool: Tailored for investors, analysts, and consultants in the biotech sector.
- User-Friendly: Intuitive design and step-by-step guidance make it accessible for all users.
Who Should Use This Product?
- Genomics Researchers: Explore advanced genomic analysis techniques using real-world data from Bionano Genomics (BNGO).
- Academics: Integrate cutting-edge genomic models into your studies or research projects.
- Investors: Evaluate your investment strategies and analyze the market performance of Bionano Genomics (BNGO).
- Bioinformatics Analysts: Enhance your analysis process with a customizable genomic data interpretation model.
- Healthcare Professionals: Understand how genomic data impacts the analysis of large biotech companies like Bionano Genomics (BNGO).
What the Template Contains
- Pre-Filled DCF Model: Bionano Genomics’ financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Bionano Genomics’ profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.